1 / 18

<Insert Presenter’s Name>

ACTION Registry. <Insert Presenter’s Name>. <Insert Event> <Insert Location> <Insert Date>. Objectives of the NCDR Registries. Provide data standardization Provide data that is Relevant, Credible, Timely, Actionable Present real life outcomes that help providers improve care

ranger
Télécharger la présentation

<Insert Presenter’s Name>

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ACTION Registry <Insert Presenter’s Name> <Insert Event> <Insert Location> <Insert Date>

  2. Objectives of the NCDR Registries • Provide data standardization • Provide data that is • Relevant, Credible, Timely, Actionable • Present real life outcomes that help providers improve care • Help Participants meet consumer, payer, and regulator demands for quality care

  3. Background • In 2004, the prevalence of CAD was 15.8 million in the U.S., causing one in five deaths1 • In 1997, there were over five million visits to U.S. emergency departments for the evaluation of chest pain and related symptoms.3 • There is strong evidence that the best treatments and strategies for these patients are not always utilized.

  4. Background Cont. • Recent registries have documented patterns of care for ACS, and have demonstrated that guidelines adherence is sub-optimal for a large proportion of ACS patients. • Despite targeted quality improvement efforts within these registries, treatment patterns for many high-risk sub-groups of patients remain sub-optimal and treatment disparities persist. • The ACTION Registry™ has thus been created to provide among the largest, most comprehensive national ACS database and quality improvement initiative ever developed, enabling hospitals to measure their performance in treating patients with ACS against national benchmarks.

  5. Purpose of the ACTION Registry • A national surveillance system • Assess characteristics, treatments, and outcomes of patients hospitalized with ACS • Focusing on high risk patients with STEMI and NSTEMI • Optimize outcomes and management of ACS patients • Implement evidence-based guideline recommendations in clinical practice • Facilitate efforts to improve quality & safety of ACS care • Investigate novel quality improvement methods

  6. ACTION Registry™ Audience: Cardiologists, emergency medicine physicians, hospitalists, primary care physicians, nurses, physician assistants, nurse practitioners, pharmacists, case managers, allied health care personnel, hospital quality improvement personnel and administrators, professional organizations, accrediting organizations, regulatory agencies, payers, pharmaceutical and device industry, and clinical research organizations

  7. Registry • No charge for participation • Funding provided by • Genentech • Bristol-Myers Squibb and Sanofi Partnership • Schering Plough Corporation • CRUSADE and NRMI sites enrolling • V1 launched • V2 being developed with CathPCI v4 for linkage Data Sharing • Early discussions with payers Research • Will be initiated in 2007 Q3 101 93 60 38

  8. About the ACTION Registry • National registry • Represents two prior ACS registries • NRMI (National Registry of Myocardial Infarction) and • CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC and AHA Guidelines) • Access to NCDR™ support services such as: • Clinical/Technical Support • Quarterly Reports • Training and Orientation • No Charge for Participation due to funding provided by • Genentech • Bristol-Myers Squibb Corporation/Sanofi Partnership • Schering Plough Corporation

  9. Registries Work • QI demonstrated in NRMI and CRUSADE outcome studies. • Registries provide: • reports to monitor use and outcomes of evidence-based medicine. • benchmarking information based on standardized definitions. • adapt and explore new metrics in a confidential environment. • help clinicians to help hospitals assess quality of care.

  10. CRUSADE

  11. Future ACTION • v.2.0 • Data vendor submission option • ORYX and CMS data submission

  12. ACTION v.2.0 Will: • Include performance measures and quality indicators from ACC/AHA, JCAHO/CMS, CRUSADE, NRMI • Include quality metrics and corresponding data elements for participant process improvement. • Incorporate the comparison of elements and definitions from ACC/AHA Data Standards, STS, CathPCI 4.0 and other NCDRTM registries • Incorporate elements from D2B Alliance (Time-to-Reperfusion) workgroup

  13. Data vendor submission option • ACTION v.2.0 will include software vendors for data submission • Specifications will be released and certification of vendors will take place early 2008

  14. ORYX and CMS data submission • data elements are aligned with the like JCAHO and CMS measures • ACTION v.2.0 will incorporate data elements in order to be aligned with CMS/JCAHO

  15. ACTION Tool Development • Take ACTION • IC3-CAD • QI Tools • NCDR Web Based Education

  16. How to Join • Download the enrollment file from www. ncdr.com • Complete your enrollment packet and submit the materials to the NCDR • Receive Welcome Kit • Complete online tool tutorial

  17. For Additional Information

More Related